Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ICON PLC (ICLR : NSDQ)
 
 • Company Description   
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.

Number of Employees: 41,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $175.21 Daily Weekly Monthly
20 Day Moving Average: 1,030,036 shares
Shares Outstanding: 80.76 (millions)
Market Capitalization: $14,149.41 (millions)
Beta: 1.20
52 Week High: $310.54
52 Week Low: $125.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.80% -5.81%
12 Week 20.08% 10.84%
Year To Date -16.45% -25.55%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN
-
DUBLIN 18,L2 00000
IRL
ph: 353-1291-2000
fax: 353-1247-6260
None http://www.iconplc.com
 
 • General Corporate Information   
Officers
Steve Cutler - Chief Executive Officer and Director
Ciaran Murray - Chair and Director
Barry Balfe - Chief Operating Officer
Nigel Clerkin - Chief Financial Officer
Ronan Murphy - Lead Independent Director

Peer Information
ICON PLC (CHCR)
ICON PLC (ESRX)
ICON PLC (MYDP)
ICON PLC (COR)
ICON PLC (GBCS)
ICON PLC (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: G4705A100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 10/22/25
Share - Related Items
Shares Outstanding: 80.76
Most Recent Split Date: 8.00 (2.00:1)
Beta: 1.20
Market Capitalization: $14,149.41 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $3.16 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $12.64 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 5.34% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 10/22/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 13.87
Trailing 12 Months: 13.61
PEG Ratio: 2.60
Price Ratios
Price/Book: 1.48
Price/Cash Flow: 8.74
Price / Sales: 1.75
EPS Growth
vs. Year Ago Period: -12.47%
vs. Previous Quarter: 2.93%
Sales Growth
vs. Year Ago Period: -4.85%
vs. Previous Quarter: 0.80%
ROE
06/30/25 - 10.95
03/31/25 - 11.46
12/31/24 - 11.81
ROA
06/30/25 - 6.23
03/31/25 - 6.49
12/31/24 - 6.65
Current Ratio
06/30/25 - 1.29
03/31/25 - 1.27
12/31/24 - 1.26
Quick Ratio
06/30/25 - 1.29
03/31/25 - 1.27
12/31/24 - 1.26
Operating Margin
06/30/25 - 12.98
03/31/25 - 13.42
12/31/24 - 13.66
Net Margin
06/30/25 - 9.82
03/31/25 - 9.25
12/31/24 - 9.56
Pre-Tax Margin
06/30/25 - 10.11
03/31/25 - 10.10
12/31/24 - 10.49
Book Value
06/30/25 - 118.32
03/31/25 - 117.65
12/31/24 - 117.92
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - 0.35
03/31/25 - 0.36
12/31/24 - 0.36
Debt-to-Capital
06/30/25 - 26.16
03/31/25 - 26.30
12/31/24 - 26.29
 

Powered by Zacks Investment Research ©